ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

AACR President Kripke Calls For Dedicated Translational Research

March 11, 1994

Reports On AACR Scientific Sessions

May 21, 1976

CTEP Analyses Proposals For Changes In Cooperative Groups

April 25, 1986

Chemical Carcinogenesis

November 18, 1994

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005